QURE – uniqure n.v. - ordinary shares (US:NASDAQ)

News

FDA reversals leave investors worrying about the fates of other experimental drugs [CNBC]
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
FDA goes on offense amid surge of criticism for recent drug decisions [CNN]
FDA goes on offense amid surge of criticism for recent drug decisions [CNN]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com